Your cart:£ 0.00(0 items) Check yourbonu$
Site search:
Categories list

Generic Fenofibrate - Tricor

Search by letter:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Tricor

Generic Tricor

Fenofibrate 160/200mg

Generic Tricor is used for controlling high cholesterol and triglyceride levels in the blood. It is used in combination with a diet low in cholesterol and saturated fat. Generic Tricor is a lipid-lowering agent. It lowers elevated blood triglyceride levels by making the liver produce fewer triglycerides and increasing the elimination of triglycerides from the blood stream.

More info »
£ 0.79 Buy now!
Country, language and currency
Social bookmarks:
Testimonials
Yes I have received the product. It came just as you said it would. I'm very pleased with the delivery. I have not tried the product yet but will soon. If it is as good as your delivery I will be most happy and you will have a customer for a very long time. - Thank you
Read more »
Special Offer!

Treatment of chronic hemodialysis patients with low-dose fenofibrate ... - 7thSpace Interactive (press release)
Treatment of chronic hemodialysis patients with low-dose fenofibrate
Santarus' CEO Presents at Bank of America Merrill Lynch 2012 Health Care ... - Seeking Alpha
Santarus' CEO Presents at Bank of America Merrill Lynch 2012 Health Care
Grace, Formac tout positive results for silica-based delivery - FierceDrugDelivery
Grace, Formac tout positive results for silica-based deliveryFierceDrugDeliveryIn the trial, researchers evaluated the bioavailability of the cholesterol fighter fenofibrate formulated with the silica platform versus that of Lipanthyl, which has the same API
Grace and Formac Pharmaceuticals Announce Successful Clinical Trial ... - MarketWatch (press release)
Grace and Formac Pharmaceuticals Announce Successful Clinical Trial
Webcast - Q1 Earnings Announcement - Canada NewsWire (press release)
Webcast - Q1 Earnings AnnouncementCanada NewsWire (press release)The Company's first product is a fenofibrate formulation marketed in the United States as Lipofen®
bookmark Bookmark this site
Subscribe to the News